|
Britain Against Cancer 2006
The All Party Parliamentary Group on Cancer's landmark annual conference for 2006 took
place on 30th November at the Queen Elizabeth II Centre in Westminster.
Britain Against Cancer has become an annual event and for the last seven years has successfully
brought together patients, health professionals and policy-makers to look at the impact of public
policy on cancer services and research.
This year’s conference examined the issue of inequalities in cancer care; be they
caused by ethnicity, disability, gender, age, the type of cancer, your postcode,
access to private medical cover or the community you live in.
Presentations from this year’s conference are now available on this site and can
be downloaded below.
Presentations from Britain Against Cancer 2006
Over 25 politicians, patients, clinicians, charity representatives and researchers
spoke in plenary and breakout sessions at Britain Against Cancer 2006, with around
350 delegates in attendance.
Below you will find some of the presentations made at the conference.
Review of the year.
-
Dr Ian Gibson MP, Chairman of the All Party Parliamentary Group on Cancer
Download... (150 Kb)
Webb outlines Lib Dem position on cancer services
Liberal Democrat Shadow Health Secretary Prof Steve Webb has today asserted
that progress had been made on cancer services but challenges - such as
health inequalities - still remained.
Speaking to the All Party Parliamentary Group on Cancer's Britain
Against Cancer Conference, Prof Webb commented that the Liberal
Democrats had commissioned a health policy working group last summer
and urged stakeholders to respond to its consultation.
He stressed the importance of focusing on prevention and welcomed the
upcoming smoking ban, which he said his Party had taken the lead on.
Voicing his agreement with the APPG's report, Prof Webb said the split
between health and social care provision was meaningless and integrated entitlements were needed.
The UK was paying too much for drugs, he continued, and a response to a
Parliamentary question revealed that the cost of new branded medicines to
the UK was higher than most other European countries.
Calling for greater transparency of drug procurement deals, he argued that if the
price could be brought down, more drugs would get through the NICE procedure.
There also needed to be greater sharing of risk and conditional approval, so
that the NHS could only pay for drugs that worked, he added.
Highlighting the fact that the DoH only allocated two per cent of its cancer
budget on prevention, Prof Webb said more should be spent on awareness and
early diagnosis.
He also warned that the re-organisation of the NHS meant that long-term planning
was constantly side-tracked and reforms were not given time to 'bed down'.
Issues surrounding the long-term position of people with cancer had to be
debated, especially with regard to prescription costs, he continued.
There was currently an arbitrary list of exemptions and the Government's
review should not be set against a background of a fixed budget.
Report Provided by DeHavilland Information Services
How the community you live in compounds inequalities (session 1)
-
Professor Mike Kelly, National Institute for Health and Clinical Excellence
Download... (557 Kb)
-
Tim Kelsey, Dr Foster Ltd
Download... (509 Kb)
I’ve got what? Rarer and less talked about cancers (session 2)
How a lack of information compounds inequalities (session 3)
-
Derryn Borley, Cancerbackup
Download... (941 Kb)
-
Jacqueline Beavan, lead researcher for the PROCEED project; Cancer Research UK Honorary Teaching Fellow, Department of Primary Care and General Practice, University of Birmingham
Download... (266 Kb)
-
Professor Amanda Ramirez, Psychosocial Oncology Group, Guy’s, King’s and St Thomas’ School of Medicine
Download... (322 Kb)
Why do more men die from cancer? (session 4)
-
Dr Chris Hiley, Head of Policy and Research, The Prostate Cancer Charity
Download... (90 Kb)
-
Colin Richardson, a personal experience of cancer
Download... (658 Kb)
-
Professor Alan White, Chair of Men’s Health Forum; Professor of Men’s Health, Leeds Metropolitan University
Download... (97 Kb)
How funding compounds inequalities (session 5)
-
Dr Peter Kirkbride, National Clinical Lead, Radiotherapy
Download... (474 Kb)
Lessons from Europe
-
Professor Jan Willem Coebergh, Professor of Cancer Surveillance, Erasmus Medical School
Download...
Britain Against Cancer Sponsorship
The All-Party Parliamentary Group on Cancer would like to
thank the sponsors of the 2006 Britain Against Cancer conference
who make a valuable contribution to the development of cancer treatments,
but who have no control over the APPG’s activities or publications:
AstraZeneca, GlaxoSmithKline, Lilly, Merck, Ortho Biotech, Pfizer, sanofi Aventis and Roche
|
